Tower Research Capital (TRC)’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-60	Closed	-$1K	–	5411
2014 Q2	$1K	Buy	+60	New	+$625	﹤0.01%	3905
2013 Q4	–	Sell	-3,593	Closed	-$19K	–	5363
2013 Q3	$19K	Buy	+3,593	New	+$15.7K	﹤0.01%	2754

Tower Research Capital (TRC)'s IDIX Position: Q3 2014 in Review

Tower Research Capital (TRC) sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 60 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in IDIX in Q3 2013 and held it in 2 quarters. The position peaked at $19K in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Tower Research Capital (TRC) reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Tower Research Capital (TRC) sold 60 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1K.
Tower Research Capital (TRC) first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
Tower Research Capital (TRC)'s IDENIX PHARMACEUTICALS INC position peaked at $19K in Q3 2013.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2014, filed 31 Oct 2014.